Biography

Dr. Michael J. Gonzalez is Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico. Dr. Gonzalez is a Fellow of the American College of Nutrition, and has authored over 150 scientific publications. He has served as a member on several scientific journal Editorial Boards, and served as consultant for several companies. He has been responsible for designing formulations of nutritional supplements and pharmaceutical products. He has obtained several research awards for his work on Nutrition and Cancer. He is currently Co- Director of RECNAC II project, and Research Director of the InBioMed Project Initiative. Dr. Gonzalez also serves as a nutrition consultant to the Puerto Rican Basketball National Team.

Dr. Gonzalez is a leader in the development of non-toxic chemotherapy treatments for cancer. His group published the first Phase-I clinical study utilizing Intravenous Vitamin C for treatment of terminal cancer patients in 2005, and also published in 2005 the most comprehensive review on Vitamin C and Cancer, as a follow-up on the work of two times Nobel Laureate, Dr. Linus Pauling. He has developed many new concepts such as the Bioenergetic theory of carcinogenesis, the systemic saturation phenomenon of intravenous vitamin C, the metabolic correction concept for disease treatment and prevention. His book (with Drs. Miranda –Massari and Saul) “I Have Cancer What Should I Do?” has received excellent reviews.


Research Interest

Development of effective; Non-toxic treatments for chronic diseases especially cancer; Changing the biochemical conditions that promote, develop and sustain the malignant state can produce inhibition of malignant cell proliferation; Increase aerobic metabolism and achieve re-differentiation; Development of non-toxic therapeutic strategies that enhance the effectiveness of other treatments or that reduce their toxicity; Ascorbic acid; Lipoic acid; acetyl L-Carnitine; Coenzyme Q10; magnesium and phospholipids to achieve Mitochondrial correction.